Physician profile
Thomas Gedulig
NPI 1316367097
$12,600.90
in general payments reported to CMS, 2019-2025
9 companies · $1,141 in 2025
The $1,141 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.10 · 2021: $89.85 · 2022: $5,048 · 2023: $1,988 · 2024: $4,322 · 2025: $1,141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,637 · Food and Beverage: $2,807 · Consulting Fee: $7.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,636.59 |
| Food and Beverage | $2,806.96 |
| Consulting Fee | $7.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,965.31 | 2022-2025 | Intellis Adaptivestim, Synchromedii, Kyphon Express II Kyphopak Tray |
| Abbott Laboratories | $2,038.56 | 2022-2023 | Proclaim |
| Boston Scientific Corporation | $969.35 | 2022-2025 | Intracept, General - Pain Management |
| Nalu Medical, INC. | $755.89 | 2025 | Nalu Neurostimulation System |
| Spr Therapeutics, INC | $278.55 | 2023-2025 | Sprint Pns System |
| Avanos Medical | $265.22 | 2024-2025 | Generator, Coolief Cooled Radiofrequency, Standard Rf Disposables |
| Heron Therapeutics, INC. | $170.37 | 2021-2022 | |
| Nevro Corp. | $145.55 | 2024 | Senza |
| Merck Sharp & Dohme LLC | $12.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Gedulig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.